Table 1.
Patient demographics and baseline characteristics of serum and ascitic fluid during first paracentesis in the overall primary cohort of patients with PMN-C < 250 cells/mm3
| Total (N = 384) | |
| Male, n (%) | 281 (73) |
| Age, yr, median (IQR) | 58 (51–63) |
| Hispanic, n(%) | 301 (78) |
| Etiology (ALD), n (%) | 257 (67) |
| Serum creatinine, mg/dL, median (IQR) | 0.90 (0.66–1.42) |
| HCV, n (%) | 77 (20) |
| INR, median (IQR) | 1.55 (1.31–1.95) |
| Total bilirubin, mg/dL, median (IQR) | 2.50 (1.20–5.70) |
| Serum albumin, g/dL, median (IQR) | 2.70 (2.30–3.20) |
| Serum sodium, mmol/L, median (IQR) | 136 (132–139) |
| Ascitic fluid total protein, g/dL, median (IQR) | 1.30 (0.90–1.80) |
| MELD-Na, median (IQR) | 20 (14–25) |
| PMN-C of first paracentesis fluid, median (IQR) | 14 (5–34) |
| PMN-% of first paracentesis fluid, % (IQR) | 10 (4–20) |
| Paracentesis to future SBP development, mo (IQR) | 4.27 (1.05–14.73) |
| Paracentesis to death or last follow-up, mo (IQR) | 6.00 (1.33–20.98) |
Analysis included those with available serum creatinine (N = 377), INR (N = 349), total bilirubin (N = 371), serum albumin (N = 370), serum sodium (N = 376), ascitic fluid total protein (N = 150), and MELD-Na (N = 346).
ALD, alcohol-associated liver disease; HCV, chronic hepatitis C virus infection; INR, international normalized ratio; IQR, interquartile range; MELD-Na, Model for End-Stage Liver Disease–Sodium; PMN-%, polymorphonuclear leukocyte percentage; PMN-C, polymorphonuclear leukocyte count; SBP, spontaneous bacterial peritonitis.